YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Bristol Myers sued for $6.4B

Posted online

Bristol Myers Squibb Co. was sued for $6.4 billion late last week.

The company is accused of allegedly delaying its Breyanzi cancer drug to avoid payments to shareholders of Celgene Corp., which it purchased in 2019.

The lawsuit was filed by UMB Bank, which is acting as a trustee on behalf of Celgene's former shareholders.

Read more from Reuters.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Letter to the Editor: No half-baked cake for our kids. No half-baked school grades, either.

Nixa Superintendent Gearl Loden weighs in on A-F grade cards.

Most Read
Update cookies preferences